Alzamend Neuro News

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Apr 3 17:05 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Apr 1 16:56 ET

Alzamend Neuro | 8-K: Current report

Mar 29 16:34 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Mar 28 16:36 ET

Alzamend Neuro | 10-Q: Quarterly report

Mar 25 17:31 ET

Alzamend Neuro | DEF 14A: Definitive information statements

Mar 25 16:50 ET

Alzamend Neuro | 8-K: Current report

Mar 22 16:34 ET

Alzamend Neuro | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Mar 18 16:31 ET

Alzamend Neuro | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Mar 13 16:38 ET

Alzamend Neuro | 8-K: Current report

Mar 7 16:38 ET

Alzamend Neuro | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MILTON C. AULT, III(40.3%),AULT ALLIANCE, INC.(25.4%), etc.

Feb 2 16:42 ET

Alzamend Neuro | 8-K: Current report

Feb 2 16:31 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Feb 2 16:31 ET

Alzamend Neuro | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MILTON C. AULT, III(29.4%),AULT LIFE SCIENCES, INC.(15.1%), etc.

Jan 25 17:26 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Jan 25 17:21 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-Director AULT MILTON C III

Jan 9 00:00 ET

Alzamend Neuro | 8-K: Current report

Jan 5 00:00 ET

Alzamend Neuro | 4: Statement of changes in beneficial ownership of securities-10% Owner AULT MILTON C III

Dec 27, 2023 00:00 ET

Alzamend Neuro: Q2 2024 Earnings Report

Dec 15, 2023 16:30 ET

Alzamend Neuro | 8-K: Current report

Nov 16, 2023 16:30 ET